Group B streptococcus vaccination in pregnant women with or without HIV in Africa: A non-randomised phase 2, open-label, multicentre trial

The Lancet Infectious Diseases

Volumn 16, Issue 5, 2016, Pages 546-555

  Heyderman, Robert S ^a,b   Madhi, Shabir A ^c,d   French, Neil ^a,e   Cutland, Clare ^c   Ngwira, Bagrey ^a   Kayambo, Doris ^a   Mboizi, Robert ^a   Koen, Anthonet ^c   Jose, Lisa ^c   Olugbosi, Morounfolu ^f   Wittke, Frederik ^g   Slobod, Karen ^f   Dull, Peter M ^f  

^a UNIVERSITY OF MALAWI   (Malawi)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f GLAXOSMITHKLINE   (United States)

^g NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOCONJUGATE GROUP B STREPTOCCUS VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTHRALGIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILL; CONTROLLED STUDY; DRUG SAFETY; ERYTHEMA; FEMALE; FEVER; GROUP B STREPTOCOCCAL INFECTION; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALAISE; MALAWI; MULTICENTER STUDY; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PAIN; PHASE 1 CLINICAL TRIAL; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RASH; SKIN INDURATION; SOUTH AFRICA; VACCINATION; AFRICA; BLOOD; CLASSIFICATION; CLINICAL TRIAL; IMMUNIZATION; IMMUNOLOGY; NEWBORN; PHASE 2 CLINICAL TRIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

ADULT; AFRICA; ANTIBODIES, BACTERIAL; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE; VACCINATION;

EID: 84957916348     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00484-3     Document Type: Article

References (32)

1. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015, 385:430-440.
2. Dagnew AF, Cunnington MC, Dube Q, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis 2012, 55:91-102.
3. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011, 127:817-826.
4. Berardi A, Rossi C, Lugli L, et al. Group B streptococcus late-onset disease: 2003-2010. Pediatrics 2013, 131:e361-e368.
5. Englund J Maternal immunization with Haemophilus influenzae type b vaccines in different populations. Vaccine 2003, 21:3455-3459.
6. Park DE, Johnson TS, Nonyane BA, et al. The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity. Pediatr Infect Dis J 2014, 33(suppl 2):S130-S139.
7. McIntyre PB, O'Brien KL, Greenwood B, van de Beek D Effect of vaccines on bacterial meningitis worldwide. Lancet 2012, 380:1703-1711.
8. Munoz FM, Ferrieri P Group B streptococcus vaccination in pregnancy: moving toward a global maternal immunization program. Vaccine 2013, 31(suppl 4):D46-D51.
9. Steinhoff MC, Omer SB, Roy E, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012, 184:645-653.
10. Maternal Immunization against tetanus WHO: Standards for Maternal and Neonatal Care, (accessed Aug 18, 2015). http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/immunization_tetanus.pdf.
11. Eaton JW, Rehle TM, Jooste S, et al. Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates. AIDS 2014, 28(suppl 4):S507-S514.
12. Dangor Z, Lala SG, Cutland CL, et al. Burden of invasive group B streptococcus disease and early neurological sequelae in South African infants. PLoS One 2015, 10:e0123014.
13. Epalza C, Goetghebuer T, Hainaut M, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010, 126:e631-e638.
14. Cutland CL, Schrag SJ, Thigpen MC, et al. Increased risk for group B streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008. Emerg Infect Dis 2015, 21:638-645.
15. Dangor Z, Kwatra G, Izu A, et al. HIV-1 is associated with lower Group B streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women. J Infect Dis 2015, 212:453-462.
16. Kerneis S, Launay O, Turbelin C, Batteux F, Hanslik T, Boelle PY Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. Clin Infect Dis 2014, 58:1130-1139.
17. Madhi SA, Leroux-Roels G, Koen A, et al. Safety and immunogenicity of an investigational maternal trivalent vaccine to prevent perinatal group B streptococcus (GBS) infection. 31st ESPID meeting; Milan; May 28-June 1, 2013. 44.
18. Donders GGG, Halperin SA, Devlieger R, et al. Maternal immunization with an investigational trivalent group B Streptococcal vaccine: a randomized controlled trial. Obstet Gynecol 2016, 127:213-221.
19. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012, 379:2162-2172.
20. Gray KJ, Kafulafula G, Matemba M, Kamdolozi M, Membe G, French N Group B streptococcus and HIV infection in pregnant women, Malawi, 2008-2010. Emerg Infect Dis 2011, 17:1932-1935.
21. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One 2011, 6:0017861.
22. The National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa, 2011 Department of Health SA, (accessed Oct 1, 2014). http://www.avert.org/south-africa-hiv-aids-statistics.htm#footnote1_mo8sf5p.
23. Bello GA, Chipeta J, Aberle-Grasse J Assessment of trends in biological and behavioural surveillance data: is there any evidence of declining HIV prevalence or incidence in Malawi?. Sex Transm Infect 2006, 82:i9-13.
24. Madhi SA, Kuwanda L, Cutland C, Holm A, Kayhty H, Klugman KP Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 2005, 24:410-416.
25. Shahid NS, Steinhoff MC, Roy E, Begum T, Thompson CM, Siber GR Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation. Vaccine 2002, 20:2404-2409.
26. Quiambao BP, Nohynek HM, Kayhty H, et al. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine 2007, 25:4470-4477.
27. Baker C, Rench MA, McInnes P Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003, 21:3468-3472.
28. Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine 2012, 30:4123-4126.
29. Baker CJ, Carey VJ, Rench MA, et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis 2014, 209:781-788.
30. Lin FYC, Philips JB, Azimi PH, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis 2001, 184:1022-1028.
31. Lin FYC, Weisman LE, Azimi PH, et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis 2004, 190:928-934.
32. Dangor Z, Kwatra G, Izu A, Lala SG, Madhi SA Review on the association of Group B streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev Vaccines 2014, 22:1-15.